SARS‑CoV‑2, the virus that causes COVID-19, continues to mutate, with some newer strains becoming less responsive to current antiviral treatments like Paxlovid. Now, University of California San Diego ...

It's possible to turn a simple, inexpensive cut of steak into a surprisingly tender and flavorful dish if you follow some ...

With climate change and higher incidences of crop diseases, global cocoa production and supply is being threatened. A ...

Alcheme Bio’s initial flagship product, Nutralase, is an enzyme blend that removes bitterness and “beaniness” notes to ...

From enzymes and lipid nanoparticles to large-scale process design, four global innovators redefine RNA-based medicine development and delivery.

Nobel laureate David Baker’s latest foundation model can design proteins that interact to any biomolecule for broad biotech applications.

Explore Intellia Therapeutics, Inc.'s outlook after Phase 3 trial concerns. See how FDA decisions may impact CRISPR therapy ...